Trials / Unknown
UnknownNCT02902393
Interest of Thromboelastography (ROTEM) as a Biomarker of Revascularisation in Stroke
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 64 (estimated)
- Sponsor
- University Hospital, Caen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Revascularisation using recombinant tPA is the reference treatment of stroke. However, the efficacy of fibrinolysis is about 50%. Several factors, including the size of thrombus, have been associated with revascularisation efficacy. The aim of this prospective study is to evaluate ex vivo the effect of tPA in patients with stroke with thromboelastography and to correlate results with the clinical outcome of patients. Results may predict revascularisation in patients with stroke.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Thromboelastography |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2018-06-01
- Completion
- 2018-09-01
- First posted
- 2016-09-15
- Last updated
- 2016-09-15
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02902393. Inclusion in this directory is not an endorsement.